Automated Antibody Verification for Lead Discovery

4 Jan 2013

Monoclonal antibodies play an increasing role as therapeutic agents in the pharmaceutical industry. Several steps within the antibody lead discovery and optimization process require the expression, purification and analytical characterization of the respective antibodies or antibody fragments. This application note presents a fully automated workflow for antibody verification using the micrOTOF-Q II from Bruker Daltonics.

• Download this article

RELATED PRODUCTS

• micrOTOF focus II